Beckmann H, Ebert M H, Post R, Goodwin F K
Pharmakopsychiatr Neuropsychopharmakol. 1979 Sep;12(5):351-6. doi: 10.1055/s-0028-1094630.
This study attempted to clarify sources of artefact in biochemical studies with affective disorders in which 3-methoxy-4-hydroxy phenylglycol (MHPG) is used as a measurement of change in central nervous system norepinephrine (NE) turnover. Substantial increases in urinary MHPG excretion occurred in ten of the 11 patients when they increased their level of physical activity (0.5 +/- .14 mg/12 hrs versus 1.54 +/- .49 mg/12 hrs). Increases were also observed in NE (19.2 +/- 5.1 microgram/12 hrs versus 25.2 +/- 3.7 microgram/12 hrs). In four patients in whom cerebrospinal fluid MHPG levels were obtained a consistent increase of MHPG levels was observed during the activity period. Elevation of these metabolites were not correlated with changes in depression as reflected by psychiatric observation and rating scales. These data reveal a considerable amount of lability in urinary and CSF MHPG levels in the face of an unchanging affective state. They ask for careful controls for activity and stress in psychiatric patients when urinary MHPG is used as an index of central NE turnover.
本研究试图阐明在情感障碍生化研究中假象的来源,此类研究中使用3-甲氧基-4-羟基苯乙二醇(MHPG)来衡量中枢神经系统去甲肾上腺素(NE)周转率的变化。11名患者中有10名在增加身体活动水平时,尿中MHPG排泄量大幅增加(从0.5±0.14毫克/12小时增至1.54±0.49毫克/12小时)。NE水平也有所增加(从19.2±5.1微克/12小时增至25.2±3.7微克/12小时)。在4名获取了脑脊液MHPG水平的患者中,在活动期间观察到MHPG水平持续升高。这些代谢物的升高与精神病学观察和评分量表所反映的抑郁变化无关。这些数据表明,在情感状态不变的情况下,尿和脑脊液中MHPG水平存在相当大的不稳定。当将尿中MHPG用作中枢NE周转率指标时,提示对精神病患者的活动和压力需进行仔细控制。